{"celex_id": "31997R0467", "uri": "http://publications.europa.eu/resource/cellar/52779485-92b4-4e54-9989-2802622263fa", "type": "Regulation", "concepts": ["2069", "2144", "2739", "2773", "5573", "932"], "title": "Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical\n", "header": "13.3.1997 EN Official Journal of the European Communities L 71/1\nCOUNCIL REGULATION (EC) No 467/97\nof 3 March 1997\nproviding for duty-free treatment for specified pharmaceutical active ingredients bearing an \u2018international non-proprietary name\u2019 (INN) from the World Health Organization and specified products used for the manufacture of finished Pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical\nTHE COUNCIL OF THE EUROPEAN UNION", "recitals": ",\nHaving regard to the Treaty establishing the European Community, and in particular Article 113 thereof,\nHaving regard to the proposal from the Commission,\nWhereas, in the course of the Uruguay Round negotiations the Community and a number of countries discussed duty-free treatment of pharmaceutical products;\nWhereas the participants in those discussions concluded that in addition to products falling within the Harmonized System (HS) Chapter 30 and HS headings 2936, 2937, 2939 and 2941, duty-free treatment should be given to designated pharmaceutical active ingredients bearing an \u2018international non-proprietary name\u2019 (INN) from the World Health Organization as well as specified salts, esters and hydrates of such INNs, and also to designated products used for the production and manufacture of finished products;\nWhereas the results of the discussions, as set out in the record of discussions, were incorporated into the tariff schedules of the participants annexed to the Marrakesh Protocol to GATT 1994;\nWhereas they also concluded that representatives of the WTO members party to the record of discussions would meet under the auspices of the Council for Trade in Goods of the WTO, normally at least once every three years \u2014 to review the product coverage with a view to including, by consensus, additional pharmaceutical products for tariff elimination;\nWhereas the first such review has taken place with the conclusion that a certain number of additional INNs and products used for production and manufacture of finished Pharmaceuticals should be granted duty-free treatment and that the list of specified prefixes and suffixes for salts and esters of INNs should be expanded;\nWhereas in the context of the review it was concluded that it was appropriate to rectify the situation with regard to certain INNs whose use was predominantly non-pharmaceutical and which had been inadvertently included among those INNs already receiving duty-free treatment,", "main_body": ["From 1 April 1997 the Community shall also accord duty-free treatment for the INNs listed in Annex I as well as the salts, esters and hydrates of such products.", "From 1 April 1997 the Community shall also grant duty-free treatment for the products used in the production and manufacture of pharmaceutical products listed in Annex II.", "From 1 April 1997 the specified prefixes and suffixes of INNs eligible for duty-free treatment shall also include those listed in Annex III.", "From 1 April 1997 the products listed in Annex IV together with the salts, esters and hydrates of such products shall no longer benefit from duty-free treatment.", "This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Communities.\nThis Regulation shall be binding in its entirety and directly applicable in all Member States."], "attachments": "Done at Brussels, 3 March 1997.\nFor the Council\nThe President\nM. de Boer\nANNEX I\nAdditional INNs to receive duty-free treatment\nCN code CAS RN Name\n2844\u00a040\u00a030 113716-48-6 Iolopride (123 I)\n142481-95-6 Technetium (99m Tc) furifosmin\n2846\u00a090\u00a000 131069-91-5 Gadoversetamide\n135326-11-3 Gadoxetic acid\n138721-73-0 Sprodiamide\n2914\u00a040\u00a090 20098-14-0 Idramantone\n2916\u00a039\u00a000 71109-09-6 Vedaprofen\n2918\u00a030\u00a000 22161-81-5 Dexketoprofen\n112665-43-7 Seratrodast\n2918\u00a090\u00a090 139403-31-9 Pimilprost\n2921\u00a049\u00a090 136236-51-6 Rasagiline\n2922\u00a049\u00a070 6582-31-6 Dapabutan\n2923\u00a090\u00a000 1794-75-8 Laurcetium bromide\n2924\u00a010\u00a000 1675-66-7 Adelmidrol\n62304-98-7 Thymalfasin\n132787-19-0 Tradecamide\n129009-83-2 Versetamide\n2924\u00a029\u00a090 147362-57-0 Loviride\n94497-51-5 Tamibarotene\n2925\u00a019\u00a080 144849-63-8 Bisnafide\n2925\u00a020\u00a000 137159-92-3 Aptiganel\n2926\u00a090\u00a080 137109-71-8 Balazipone\n147076-36-6 Laflunimus\n2928\u00a000\u00a090 141579-54-6 Fenleuton\n2930\u00a090\u00a016 87573-01-1 Salnacedin\n2930\u00a090\u00a070 90357-06-5 Bicalutamide\n112573-72-5 Dexecadotril\n107023-41-6 Pobilukast\n81110-73-8 Racecadotril\n2931\u00a000\u00a050 132236-18-1 Zifrosilone\n2931\u00a000\u00a080 114084-78-5 Ibandronic acid\n124351-85-5 Incadronic acid\n63132-39-8 Olpadronic acid\n2932\u00a099\u00a070 105674-77-9 Lanproston\n2932\u00a099\u00a090 123407-36-3 Arteflene\n132017-01-7 Bervastatin\n110816-79-0 Cromoglicate lisetil\n149494-37-1 Ebalzotan\n151581-24-7 Iralukast\n113806-05-6 Olopatadine\n139110-80-8 Zanamivir\n2933\u00a029\u00a090 158682-68-9 Elisartan\n116684-92-5 Galdansetron\n89371-44-8 Imidaprilat\n138402-11-6 Irbesartan\n118072-93-8 Zoledronic acid\n2933\u00a039\u00a095 119257-34-0 Besipirdine\n118248-91-2 Fodipir\n155415-08-0 Inogatran\n121750-57-0 Itameline\n144412-49-7 Lamifiban\n155319-91-8 Mangafodipir\n150443-71-3 Nicanartine\n29876-14-0 Nicotredole\n144035-83-6 Piclamilast\n137795-35-8 Spiroglumide\n147025-53-4 Talsaclidine\n149488-17-5 Trovirdine\n2933\u00a040\u00a010 127294-70-6 Balofloxacin\n143383-65-7 Premafloxacin\n143224-34-4 Telinavir\n2933\u00a040\u00a090 96946-42-8 Cisatracurium besilate\n158966-92-8 Montelukast\n136668-42-3 Quiflapon\n2933\u00a059\u00a070 127266-56-2 Adatanserin\n106941-25-7 Adefovir\n113852-37-2 Cidofovir\n150756-35-7 Efletirizine\n119687-33-1 Iganidipine\n127759-89-1 Lobucavir\n140945-32-0 Mapinastine\n134208-17-6 Mazapertine\n96604-21-6 Ocinaplon\n148504-51-2 Ripisartan\n115762-17-9 Ruzadolane\n118420-47-6 Tagorizine\n137234-62-9 Voriconazole\n151319-34-5 Zaleplon\n2933\u00a079\u00a000 148396-36-5 Fradafiban\n74436-00-3 Geclosporin\n143943-73-1 Lirequinil\n106730-54-5 Olprinone\n135548-15-1 Oxeclosporin\n145733-36-4 Tasosartan\n143343-83-3 Toborinone\n2933\u00a090\u00a095 137882-98-5 Abitesartan\n114607-46-4 Acitazanolast\n120511-73-1 Anastrozole\n134523-00-5 Atorvastatin\n128270-60-0 Bivalirudin\n139481-59-7 Candesartan\n54278-85-2 Candocuronium iodide\n105806-65-3 Efegatran\n62568-57-4 Emideltide\n120081-14-3 Goralatide\n142880-36-2 Ilornastat\n62732-44-9 Ipidacrine\n116287-14-0 Lanperisone\n112809-51-5 Letrozole\n116644-53-2 Mibefradil\n136122-46-8 Mipitroban\n144702-17-0 Pomisartan\n132036-88-5 Ramosetron\n106308-44-5 Rufinamide\n144701-48-4 Telmisartan\n147059-72-1 Trovafloxacin\n2934\u00a010\u00a000 149079-51-6 Cartasteine\n128312-51-6 Cinalukast\n51287-57-1 Denotivir\n101001-34-7 Pamicogrel\n136433-51-7 Tazofelone\n138742-43-5 Zankiren\n2934\u00a020\u00a090 144665-07-6 Lubeluzole\n150915-41-6 Perospirone\n146939-27-7 Ziprasidone\n2934\u00a090\u00a060 130370-60-4 Batimastat\n133040-01-4 Eprosartan\n135202-79-8 Ilonidap\n114686-12-3 Imitrodast\n132418-36-1 Rocepafant\n132418-35-0 Setipafant\n2934\u00a090\u00a070 125533-88-2 Mofarotene\n127045-41-4 Pazufloxacin\n2934\u00a090\u00a080 118292-40-3 Tazarotene\n2934\u00a090\u00a098 151356-08-0 Afovirsen\n138298-79-0 Alnespirone\n152317-89-0 Alniditan\n153420-96-3 Atibeprone\n143393-27-5 Azalanstat\n149908-53-2 Azimilide\n150490-85-0 Berupipam\n154361-50-9 Capecitabine\n133099-04-4 Darifenacin\n137500-42-6 Darsidomine\n114030-44-3 Dexpemedolac\n115464-77-2 Elopiprazole\n141790-23-0 Fozivudine tidoxil\n122254-45-9 Glenvastatin\n143443-90-7 Ifetroban\n82857-82-7 Ilepcimide\n104454-71-9 Ipenoxazone\n118288-08-7 Lafutidine\n138068-37-8 Lepirudin\n78994-23-7 Levormeloxifene\n116476-16-5 Levosemotiadil\n148152-63-0 Napitane\n84558-93-0 Netivudine\n147432-77-7 Ontazolast\n139225-22-2 Panamesine\n103255-66-9 Pazinaclone\n123447-62-1 Prulifloxacin\n131986-45-3 Xanomeline\n145781-32-4 Zolasartan\n2935\u00a000\u00a090 147536-97-8 Bosentan\n136817-59-9 Delavirdine\n119905-05-4 Delequamine\n112966-96-8 Domitroban\n125279-79-0 Ersentilide\n139133-26-9 Lexipafant\n154397-77-0 Napsagatran\n139133-27-0 Nupafant\n116649-85-5 Ramatroban\n133276-80-9 Samixogrel\n146623-69-0 Saprisartan\n149556-49-0 Susalimod\n144494-65-5 Tirofiban\n139308-65-9 Tolafentrine\n107753-78-6 Zafirlukast\n2936\u00a029\u00a090 131875-08-6 Lexacalcitol\n2937\u00a010\u00a010 9002-68-0 Follitropin alfa\n152923-57-4 Lutropin alfa\n2937\u00a022\u00a000 103466-73-5 Icometasone enbutate\n2937\u00a029\u00a090 144459-70-1 Rofleponide\n2937\u00a099\u00a000 124478-60-0 Aglepristone\n140703-51-1 Examorelin\n133107-64-9 Insulin lispro\n144743-92-0 Teverelix\n2939\u00a050\u00a090 151581-23-6 Apaxifylline\n132210-43-6 Cipamfylline\n100324-81-0 Lisofylline\n98833-92-2 Stacofylline\n2939\u00a090\u00a090 135905-89-4 Mirisetron\n117086-68-7 Ricasetron\n25775-90-0 Zucapsaicin\n2940\u00a000\u00a090 133692-55-4 Seprilose\n2941\u00a090\u00a000 127785-64-2 Basifungin\n116853-25-9 Cefluprenam\n122841-10-5 Cefoselis\n156131-91-8 Dimadectin\n123997-26-2 Eprinomectin\n149951-16-6 Lenapenem\n108852-90-0 Nemorubicin\n159445-62-2 Orientiparcin\n156769-21-0 Sanfetrinem\n3001\u00a090\u00a099 120993-53-5 Desirudin\n3002\u00a010\u00a091 143653-53-6 Abciximab\n156227-98-4 Afelimomab\n151763-64-3 Capromab\n152923-56-3 Dacliximab\n145832-33-3 Detumomab\n142864-19-5 Enlimomab\n152981-31-2 Inolimomab\n150631-27-9 Nacolomab tafenatox\n159445-64-4 Odulimomab\n147191-91-1 Priliximab\n153101-26-9 Regavirumab\n148189-70-2 Votumumab\n3002\u00a010\u00a095 143090-92-0 Anakinra\n143631-61-2 Atexakin alfa\n148637-05-2 Cilmostim\n154725-65-2 Epoetin epsilon\n148363-16-0 Epoetin omega\n102786-52-7 Eptacog alfa (activated)\n156679-34-4 Lenercept\n124146-64-1 Mobenakin\n0-00-0 Moroctocog alfa\n148641-02-5 Muplestim\n139076-62-3 Octocog alfa\n3003\u00a039\u00a000 0-00-0 Plusonermin\n3003\u00a090\u00a090 0-00-0 Fuladectin\n3507\u00a090\u00a090 143831-71-4 Dornase alfa\n154248-97-2 Imiglucerase\n149394-67-2 Ledimase\n156616-23-8 Monteplase\n159445-63-3 Nateplase\n155773-57-2 Pegorgotein\n3911\u00a090\u00a019 95522-45-5 Colestilan\n31512-74-0 Polixetonium chloride\n3913\u00a090\u00a080 39464-87-4 Betasizofiran\n0-00-0 Certoparin sodium\n0-00-0 Minolteparin sodium\nANNEX II\nAdditional pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to receive duty-free treatment\nCN code CAS RN Name\n2843\u00a030\u00a000 12192-57-3 (alpha-D-glucopyranosylthio) gold\n2903\u00a069\u00a090 42074-68-0 1-chloro-2-(chlorodiphenylmethyl) benzene\n76283-09-5 alpha,4-dibromo-2-fluorotoluene\n2906\u00a029\u00a090 104265-58-9 2-[(1 S,2R)-6-fluoro-2-hydroxy-1 -isopropyl-1,2,3,4-tetrahydro-2-naphthyl] ethyl p-toluenesulfonate\n2907\u00a029\u00a090 700-13-0 2,3,5-tximethylhydroquinone\n2909\u00a050\u00a090 63659-16-5 4-[2-(cyclopropylmethoxy) ethyl] phenol\n2914\u00a040\u00a090 80-75-1 11-alpha-hydroxypregn-4-ene-3,20-dione\n2914\u00a050\u00a000 2107-69-9 5,6-dimethoxyindan-1 -one\n24916-90-3 9-beta,11-beta-epoxy-17,21-dihydroxy-l6-alpha-methylpregna-l,4-diene-3,20-dione\n2914\u00a070\u00a090 83881-08-7 21-chloro-9-beta, 11 -beta-epoxy-17-hydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione\n2915\u00a039\u00a090 979-02-2 20-oxopregna-5,l 6-dien-3-beta-yl acetate\n2915\u00a090\u00a020 638-41-5 pentyl chloroformate\n2916\u00a039\u00a000 49708-81-8 trans-4-(p-chlorophenyl)cyclohexanecarboxylic acid\n2917\u00a019\u00a090 48059-97-8 (E)-oct-4-ene-1,8-dioic acid\n71170-82-6 triethyl 3-bromopropane-1,1,1-tricarboxylate\n2917\u00a039\u00a080 27932-00-9 indan-5-yl hydrogen phenylmalonate\n2918\u00a013\u00a000 2743-38-6 dibenzoyl-L-tartaric acid\n2918\u00a017\u00a000 4358-88-7 ethyl DL-mandelate\n2918\u00a019\u00a080 56188-04-6 {(1 R,3R,5S)-3,5-dihydroxy-2-[(E)-(3S)-3-hydroxyoct-1 -enyl]cyclopentyl}acetic acid\n2918\u00a029\u00a090 167678-46-8 3-chloroformyl-o-tolyl acetate\n2918\u00a030\u00a000 56105-81-8 (R)-2-(3-benzoylphenyl) propionic acid\n22161-86-0 (RS)-2-(3-benzoylphenyl) propionic acid\n78834-75-0 enthyl 7-chloro-2-oxoheptanoate\n1944-63-4 3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxooctahydro-1 H-inden-4-yl]propionic acid\n39562-17-9 methyl 2-(3-nitrobenzylidene)-3-oxobutyrate\n2918\u00a090\u00a090 26159-31-9 (RS)-2-(6-methoxy-2-naphthyl)propionic acid\n105560-93-8 methyl (2R,3S)-2,3-epoxy-3-(4-methoxyphenyl) propionate\n40098-26-8 methyl 7-[(3RS)-3-hydroxy-5-oxocyclopent-1-enyl]heptanoate\n2921\u00a019\u00a080 4261-68-1 (2-chloroethyl) diisopropylamine hydrochloride\n2921\u00a059\u00a090 122-75-8 N, N'-dibenzylethylenediammonium di (acetate)\n2922\u00a019\u00a000 126456-43-7 (1S,2R)-1-aminoindan-2-ol\n68047-07-4 4'-[2-(dimethylamino) ethoxy]-2-phenylbutyrophenone\n2922\u00a030\u00a000 784-38-3 2-amino-5-chloro-2'-fluorobenzophenone\n156732-13-7 (S)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one\n2922\u00a049\u00a070 37441-29-5 5-amino-2,4,6-triiodoisophthaloyl dichloride\n42854-62-6 benzyl L-alaninate--p-toluenesulfonic acid (1:1)\n39878-87-0 (-)-alpha-(chloroformyl) benzylammonium chloride\n54527-73-0 2-(N-methylbenzylamino) ethyl 3-aminobut-2-enoate\n81677-60-3 methyl (4-nitrophenyl)-L-alaninate\n949-99-5 3-(4-nitrophenyl)-L-alanine\n2924\u00a010\u00a000 153758-31-7 (2S)-2-amino-3-hydroxy-N-pentylpropionamide--oxalic acid (1:1)\n138531-07-4 L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-o\n2924\u00a029\u00a090 40188-45-2 3'-acetyl-4'-hydroxybutyranilide\n1149-26-4 N-(benzyloxycarbonyl)-L-valine\n116661-86-0 (2S,3S)-3-(tert-butoxycarbonylamino)-2-hydroxy-4-phenylbutyric acid\n144163-85-9 tert-butyl [(1S,3S,4S)-4-amino-1-benzyl-3-hydroxy-5-phenylpentyl] carbamate\n149451-80-9 tert-butyl [(1S,2S)-1-benzyl-2,3-dihydroxypropyl] carbamate\n98737-29-2 tert-butyl {(S)-alpha-[(S)-oxiranyl]phenethyl}carbamate\n0-00-0 2-chloro-N-[2-(2-chlorobenzoyl)-4-nitrophenyl] acetamide\n125971-96-2 2-[alpha-(4-fluorobenzoyl)benzyl]-4-methyl-3-oxovaleranilide\n32981-85-4 methyl (2R,3S)-3-benzamido-2-hydroxy-3-phenylpropionate\n2925\u00a019\u00a080 151860-15-0 meso-N-benzyl-3-nitrocyclopropane-1,2-dicarboximide\n97338-03-9 ethyl (S)-3-(4-aminopheynl)-2-phthalimidopropionate hydrochloride\n94213-26-0 ethyl (S)-3-{4-[bis(2-chloroethyl)amino]phenyl}-2-phthalimidopropionate hydrochloride\n2926\u00a090\u00a080 58311-73-2 (Z)-(2-cyanovinyl)trimethylammonium p-toluenesulfonate\n133481-10-4 ethyl (l-cyanocyclohexl)acetate\n123632-23-5 4-(2,2,3,3-tetrafluoropropoxy)cinnamonitrile\n2928\u00a000\u00a090 94213-23-7 (Z)-[cyano(2,3-dichlorophenyl)methylene]carbazamidine\n2930\u00a090\u00a016 159453-24-4 N-(benzyloxycarbonyl)-S-phenyl-L-cysteine\n2930\u00a090\u00a070 159878-02-1 benzyl (1 R,2S)-3-chloro-2-hydroxy-1 -(phenylthiomethyl)propylcarbamate\n136511-43-8 ethyl N-{2-[(acetylthio)methyl]-3-(o-tolyl)-1-oxopropyl}-L-methionate\n2932\u00a019\u00a000 97148-39-5 ammonium (Z)-2-methoxyimino-2-(2-furyl)acetate\n2932\u00a029\u00a080 517-23-7 alpha-acetyl-gamma-butyrolactone\n6559-91-7 4'-demethylepipodophyllotoxin\n39521-49-8 (3aR,4bS,4R,4aS,5aS)-4-(5,5-dimethyl-1,3-dioxolan-2-yl)hexahydrocyclopropa[3,4]cyclopenta[l,2-b]furan-o 2(3H)-one\n39746-01-5 (3aR,4R,5R,6aS)-4-formyl-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate\n976-70-5 3-oxopregn-4-ene-21,17-alpha-carbolactone\n2932\u00a099\u00a050 32981-86-5 10-deacetylbaccatin III\n2932\u00a099\u00a070 7512-17-6 2-acetamido-2-deoxy-beta-D-glucopyranose\n79944-37-9 trans-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol\n125971-94-0 tert-butyl [(4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]acetate\n467-55-0 3-beta-hydroxy-5-alpha-spirostan-12-one\n533-31-3 3,4-(methylenedioxy)phenol\n2933\u00a011\u00a090 6150-97-6 magnesium bis [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1 H-pyrazol-4-yl)methylamino]methane- sulfonate\n2933\u00a019\u00a090 27511-79-1 3-aminopyrazole-4-carboxamide hemisulfate\n2933\u00a029\u00a090 4897-25-0 5-chloro-1-methyl-4-nitroimidazole\n2933\u00a039\u00a095 142057-79-2 (RS)-2[(1 -benzyl-4-piperidyl)methyl]-5,6-dimethoxyindan-l -one\n120014-07-5 2-[(l-benzyl-4-piperidyl)methylene]-5,6-dimethoxyindan-1-one\n6935-27-9 benzyl(2-pyridy l)amine\n87848-95-1 6-bromo-2-pyridyl-p-tolyl ketone\n32998-95-1 N-(tert-butyl)-3-methylpyridine-2-carboxamide\n84449-80-9 1-[2-(4-carboxyphenoxy)ethyl]piperidinium chloride\n83949-32-0 4-carboxy-4-phenylpiperidinium p-toluenesulfonate\n38092-89-6 8-chloro-6,11-dihydro-11-(l-methyl-4-piperidylidene)-5H-benzo[5,6]cyclohepta[l,2-b]pyridine\n31255-57-9 3-[2-(3-chlorophenyl)ethyl]pyridine-2-carbonitrile\n107256-31-5 3-[2-(3-chlorophenyl)ethyl]-2-pyridyl 1 -methyl-4-piperidyl ketone hydrochloride\n6298-19-7 2-chloro-3-pyridylamine\n5424-11-3 2,2-diphenyl-4-piperidinovaleronitrile\n108555-25-5 1-[2-(4-methoxyphenyl)ethyl]-4-piperidylamine dihydrochloride\n4046-24-6 5-(l -methyl-4-piperidyl)-5H-dibenzo[a,d]cyclohepten-5-ol hydrochloride\n139886-04-7 1-methyl-1,2,5,6-tetrahydropyridine-3-carbaldehyde (E)-O-methyloxime hydrochloride\n70708-28-0 1-(2-pyridyl)-3-(pyrrolidin-1-yl)-1-(p-tolyl)propan-1-ol\n1619-34-7 quinuclidin-3-ol\n2933\u00a040\u00a010 105956-96-5 7-[3-(tert-butoxycarbonylamino)pyrrolidin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroc quinoline-3-carboxylic acid\n86393-33-1 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid\n112811-72-0 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid\n98349-25-8 ethyl 1 -cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate\n2933\u00a040\u00a090 159878-04-3 benzyl (1S,2S)-3-[3S,4aS,8aS)-3-tert-butylcarbamoylperhydro-2-isoquinolyl]-2-hydroxy-1-(phenylthioc methyl)propylcarbamate\n159989-64-7 (3S,4aS,8aS)-N-(tert-butyl)-2-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl] perhydroisoquinoline-3-carboxamide\n159989-65-8 (3S,4aS,8aS)-N-(tert-butyl)-2-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl] perhydroisoquinoline-3-carboxamide\u2014methanesulfonic acid (1:1)\n120578-03-2 3-[(E)-2-(7-chloro-2-quinolyl)vinyl]benzaldehyde\n1087-69-0 (9S,13S,14S)-3-methoxymorphinan hydrochloride\n64228-78-0 pentamethylene bis {3-[10-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolyl] propionate]- -oxalic acid (1:2)\n2933\u00a059\u00a070 75128-73-3 2-[(2-acetamido-6-oxo-6,9-dihydro-1H-purin-9-yl)methoxy]ethyl acetate\n3056-33-5 N-(9-acetyl-6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide\n10310-21-1 2-amino-6-chloropurine\n124832-31-1 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-(benzyloxycarbonyl)-L-valinate\n150378-17-9 (2R,4S)-2-benzyl-5-[2-(tert-butylcarbamoyl)-4-(3-pyridylmethyl)piperazin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxyindan-1-yl]valeramide\n157810-81-6 (2R,4S)-2-benzyl-5-[2-(tert-butylcarbamoyl)-4-(3-pyridylmethyl)piperazin-1-yl]-4-hydroxy-N-[(lS,2R)-c 2-hydroxyindan-1-yl]valeramide sulfate\n150323-35-6 (3S)-1-(tert-butoxycarbonyl)-3-(tert-butylcarbamoyl)piperazine\n41202-32-8 1-(2-chlorophenyl)piperazine hydrochloride\n13078-15-4 1-(3-chlorophenyl)piperazine hydrochloride\n71-30-7 cytosine\n149062-75-9 1,3-dichloro-6,7,8,9,1 0,1 2-hexahydroazepino[2,1 -b]quinazoline hydrochloride\n41202-77-1 1-(2,3-dichlorophenyl)piperazine hydrochloride\n56177-80-1 2-ethoxy-5-fluoropyrimidin-4(1 H)-one\n112733-45-6 ethyl (7-chloro-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-l -yl)acetate\n59703-00-3 4-ethyl-2,3-dioxopiperazine-l-carbonyl chloride\n64090-19-3 1-(4-fluorophenyl)piperazine dihydrochloride\n147539-21-7 isopropyl[2-(piperazin-1-yl)-3-pyridyl]amine\n35386-24-4 1-(2-methoxyphenyl)piperazine\n5464-78-8 1-(2-methoxyphenyl)piperazine hydrochloride\n145012-50-6 (7RS,9aRS)-perhydropyrido[l,2-a]pyrazin-7-ylmethanol\n2210-93-7 1-phenylpiperazinium chloride\n111641-17-9 4-(piperazin-1-yl)-2,6-bis(pyrrolidin-1-yl)pyrimidine\n68-94-0 purin-6(1 H)-one\n70849-60-4 1-(o-tolyl)piperazine hydrochloride\n2933\u00a069\u00a080 58909-39-0 tetrahydro-2-methyl-3-thioxo-1,2,4-triazine-5,6-dione\n2933\u00a079\u00a000 135297-22-2 (3S,4R)-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(lR,3S)-3-methoxy-2-oxocyclohexyl]azetidin-2-one\n141646-08-4 1-|[(cyclohexyloxy)carbonyl]oxy}ethyl 1 -(1 -hydroxyethyl)-5-methoxy-2-oxo-1,2,5,6,7,8,8 a,8b-octahydroazeto*c [2,1 -a]isoindole-4-carboxylate\n132127-34-5 (3R,4S)-3-hydroxy-4-phenylazetidin-2-one\n75363-99-4 p-nitrobenzyl (2R,5R,6S)-6-[(R)-1-hydroxyethyl]-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate\n141316-45-2 potassium 1 -(1 -hydroxyethyl)-5-methoxy-2-oxo-1,2,5,6,7,8,8 a,8b-octahydroazeto[2,1 -a]isoindole-4-carbc oxylate\n2933\u00a090\u00a060 59467-64-0 [7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-yl]methylamine\n59469-29-3 [7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1 H-l,4-benzodiazepin-2-ylmethyl]ammonium bis(maleate)\n59467-69-5 8-chloro-6-(2-fluorophenyl)-1-methyl-3a,4-dihydro-3H-imidazo[l,5-a][l,4]benzodiazepine\n59469-63-5 7-chloro-5-(2-fluorophenyl)-3-methyl-2-(nitromethylene)-2,3-dihydro-1 H-1,4-benzodiazepine 4-oxide\n59467-63-9 7-chloro-5-(2-fluorophenyl)-2(nitromethylene)-2,3-dihydro-1 H-1,4-benzodiazepine\n2933\u00a090\u00a095 130404-91-0 N-[(R)-2-({(R)-2-[(2-adamantyloxycarbonyl)amino]-3-(lH-indol-3-yl)-2-methyl-1-oxopropyl}amino)-1- phenylethyl]succinamic acid-1-deoxy-1-methylamino-D-glucitol (1:1)\n122536-48-5 3-[(S)-3-(L-alanylamino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3- carboxylic acid hydrochloride\n122536-91-8 7-{(S)-3-[(S)-2-(tert-butoxycarbonylamino)-1-oxopropylamino]pyrrolidin-1-yl}-1-cyclopropyl-6-fluoro-4- oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid\n134575-17-0 tert-butyl meso-3-azabicyclo[3.1.0]hex-6-ylcarbamate\n122536-66-7 tert-butyl [(S)-1-methyl-2-oxo-2-[(S)-pyrrolidin-3-ylamino]ethyl}carbamate\n140629-77-2 tert-butyl [(RS)-pyrrolidin-3-yl] carbamate\n100361-18-0 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid\n38150-27-5 5-chloro-2-[3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl]ben2Ophenone\n36916-19-5 5-chloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)benzophenone\n54196-62-2 2',5-dichloro-2-[3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl]benzophenone\n54196-61-1 2',5-dichloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)benzophenone\n141113-28-2 (E)-( + )-2-(2,4-difluorophenyl)-1 -[3-[4-(2,2,3,3-tetrafluoropropoxy)styryl]-1 H-1,2,4-triazol-1 -yl}-3-(1 H- 1,2,4-triazol-1-yl)propan-2-ol\n141113-41-9 (R)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1 -yl)propane-1,2-diol\n144034-80-0 dimethyl{2-[5-(1 H-1,2,4-triazol-1-ylmethyl)indol-3-yl]ethyl}amine\n122665-86-5 ethyl [3-(cyanomethyl)-4-oxo-3,4-dihydrophthalazin-1 -yl]acetate\n41340-36-7 2-(7-ethyl-lH-indol-3-yl)ethanol\n95885-13-5 5-ethyl-4-(2-phenoxyethyl)-4H-1,2,4-triazol-3(2H)-one\n96107-94-7 ethyl 1 H-tetrazole-5-carboxylate, sodium salt\n96034-57-0 trans-4-hydroxy-1-(4-nitrobenzyloxycarbonyl)-L-proline\n160194-26-3 2-iodo-4-(1 H-1,2,4-triazol-1-ylmethyl)aniline\n66635-71-0 isopropyl 2,3-dihydro-1 H-pyrrolizine-1-carboxylate\n4928-88-5 methyl 1 H-1,2,4-triazole-3-carboxylate\n0-00-0 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid sulfate\n112193-77-8 1,4,7,10-tetraazoniacyclododecane bis(sulfate)\n3641-08-5 1 H-l,2,4-triazole-3-carboxamide\n4928-87-4 1 H-1,2,4-triazole-3-carboxylic acid\n6969-71-7 1,2,4-triazolo[4,3-a]pyridin-3(2H)-one\n2934\u00a010\u00a000 171485-87-3 2-[4-(2-amino-4-oxo-4,5-dihydrothiazol-5-ylmethyl)phenoxymethyl]-2,5,7,8-tetramethylchroman-6-yl acetate\n65872-41-5 (Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetic acid\n64486-18-6 (Z)-2-[2-(chloroacetamido)thiazol-4-yl]-2-(methoxyimino) acetic acid\n76823-93-3 1-{4-[(2-cyanoethyl)thiomethyl]thiazol-2-yl}guanidine\n139340-56-0 [5-[(Z)-3,5-di(tert-butyl)-4-hydroxybenzylidene]-4-oxo-4,5-dihydrothiazol-2-yl]ammonium methanec sulfonate\n64485-88-7 ethyl (Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino) acetate\n66339-00-2 ethyl 2-(hydroxyimino)-2-[2-(tritylamino)thiazol-4-yl]acetate hydrochloride\n88046-01-9 2-guanidinothiazol-4-ylmethyl carbamimidothioate dihydrochloride\n154212-61-0 N-[2-isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine\n66215-71-2 (Z)-2-methoxyimino-2-[2-(tritylamino)thiazol-4-yl] acetic acid\n154212-59-6 4-nitrophenyl thiazol-5-ylmethyl carbonate hydrochloride\n38585-74-9 thiazol-5-ylmethanol\n155213-67-5 thiazol-5-ylmethyl (lS,2S,4S)-1-benzyl-2-hydroxy-4-{(2S)-2-[3-(2-isopropylthiazol-4-ylmethyl)-3-methyl ureido]-3-methylbutyramido}-5-phenylpentylcarbamate\n2934\u00a020\u00a050 80756-85-0 S-(benzothiazol-2-yl) (Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminothioacetate\n2934\u00a020\u00a090 87691-88-1 1-(1,2-benzisothiazol-3-yl)piperazine hydrochloride\n2934\u00a090\u00a050 111974-69-7 2-{2-[4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethoxy}ethanol\n42399-49-5 (2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one\n2934\u00a090\u00a060 115787-67-2 2-(2-amino-5-nitro-6-oxo-1,6-dihydropyrimidin-4-yl)-3-(3-thienyl)propiononitrile\n117829-20-6 2-amino-7-thenyl-1,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one hydrochloride\n112887-68-0 N-{5-[(1,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)methylamino]-2-thenoyl}-L-glutamic acid\n161005-84-1 (S)-N,N-dimethyl-[3-(2-thienyl)-3-(1-naphthyloxy)propyl]amine-phosphoric acid (1:1)\n104795-66-6 3-isopropoxy-5-methoxy-N-(1H-tetrazol-5-yl)benzo[b]thiophene-2-carboxamide\n104795-67-7 3-isopropoxy-5-methoxy-N-(1H-tetrazoI-5-yl)benzo[b]thiophene-2-carboxamide-1H-imidazole (1:1)\n104795-68-8 3-isopropoxy-5-methoxy-N-(1H-tetrazol-5-yl)benzo[b]thiophene-2-carboxamide, sodium salt\n63675-74-1 6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene\n138564-59-7 5-methyl-2-(2-nitroanilino)thiophene-3-carbonitrile\n2934\u00a090\u00a070 25229-97-4 2-cyano-3-morpholinoacrylamide\n2934\u00a090\u00a080 119221-49-7 5-[(2-aminoethyl)amino]-2-(2-diethylaminoethyl)-2H-[1]benzothiopyrano[4,3,2-cd]indazol-8-ol\n147086-81-5 (4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol 7,7-dioxide\n2934\u00a090\u00a098 58-61-7 adenosine\n152305-23-2 (S)-4-(4-aminobenzyl)oxazolidin-2-one\n71420-85-4 7-amino-3-[1-(sulfomethyl)-1H-tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acid, sodium salt\n29706-84-1 3'-azido-3'-deoxy-5'-0-tritylthymidine\n51762-51-7 benzhydryl 3-hydroxy-7-(phenylacetamido)cepham-4-carboxylate\n110314-42-6 5-[(benzofuran-2-ylcarbonyl)amino]indole-2-carboxylic acid\n131986-28-2 3-(4-chloro-1,2,5-thiadiazol-3-yl)pyridine\n107452-89-1 omega-conotoxin M VIIA\n126429-09-2 2-(dichloromethyl)-4,5-dihydro-5-(4-mesylphenyl)oxazol-4-ylmethanol\n126813-11-4 (4R,5R)-2-(dichloromethyl)-4,5-dihydro-5-(4-mesylphenyl)oxazol-4-ylmethanol\n4097-22-7 2',3'-dideoxyadenosine\n139264-17-8 (S)-4-{[3-(2-dimethylaminoethyl)-1H-indol-5-yI]methyl}oxazolidin-2-one\n110351-94-5 (S)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione\n140841-32-3 6-[3-fluoro-5-(4-methoxytetrahydropyran-4-yl)phenoxymethyl]-1-methyl-2-quinolone\n94732-98-6 1-(1-{3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl}-4-piperidyl)-2,3-dihydro-1H-benzimidazole-2-thione\n125995-03-1 (4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-4-hydroxy tetrahydro-2H-pyran-2-one\n131988-19-7 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1-methylpyridinium iodide\n147027-10-9 (1R,2S,5R)-menthyl (2R,5S)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-1,3-oxathiolane-2-carboxylate\n147126-62-3 (1R,2S,5R)-menthyl (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylate\n104218-44-2 3'-O-mesyl-5'-O-tritylthymidine\n27255-72-7 3-methyl-7-(phenylacetamido)-3-cephem-4-carboxylic acid\n0-00-0 (1R,2S,3S,6R)-[(S)-1-phenylethyl]-3,6-epoxytetrahydrophthalimide\n32231-06-4 1-piperonylpiperazine\n55612-11-8 5'-O-tritylthymidine\n2935\u00a000\u00a090 151140-66-8 (4-amino-3-iodophenyl)-N-methylmethanesulfonamide\n112101-81-2 5-[(R)-(2-aminopropyl)]-2-methoxybenzenesulfonamide\n120298-38-6 N-(5,6-dihydro-6-methyl-2-sulfamoyl-4H-thieno[2,3-b]thiopyran-4-yl)acetamide 7,7-dioxide\n150975-95-4 5-methanesulfonamidoindole-2-carboxylic acid\n84522-34-9 sodium 4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulfonamide\n2939\u00a010\u00a000 66820-84-6 (RS)-tetrahydropapaverine hydrochloride\n2940\u00a000\u00a090 13035-61-5 1,2,3,5-tetraacetyl-beta-D-ribofuranose\n3824\u00a090\u00a064 330-95-0 1,3-bis(4-nitrophenyl)urea--4,6-dimethylpyrimidin-2-ol (1:1)\n104832-01-1 (R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline~dibenzoyl-L-tartaric acid (1:1)\n0-00-0 Intermediate concentrate obtained from a genetically-modified Escherichia coli fermentation medium, containing human granulocyte-macrophage colony-stimulating factor; for use in the manufacture of medicaments of HS No 30.02\n0-00-0 Intermediate concentrate obtained from a genetically-modified Escherichia coli fermentation medium, containing human interferon alpha-2b; for use in the manufacture of medicaments of HS No 30.02\n0-00-0 Intermediate concentrates obtained from a Micromonospora inyoensis fermentation medium used for the manufacture of the antibiotics sisomicin (INN) and netilmicin (INN)\n0-00-0 Intermediate concentrates obtained from a Micromonospora purpurea fermentation medium used for the manufacture of the antibiotics gentamicin sulfate (INNM) and isepamicin (INN)\n3824\u00a090\u00a095 0-00-0 ethyl 7-chloro-2-oxoheptanoate, in the form of a solution in toluene\n3911\u00a090 162430-94-6 1,6-hexanediamine, polymer with 1,10-dibromodecane\n3913\u00a090\u00a080 83513-48-8 danaparoid sodium\nANNEX III\nAdditions to the list of prefixes and suffixes which, in combination with the INNs, describe salts, esters or hydrates of INNs\nN-acetylglycinate\nacistrate\nacoxil\namsonate\nbenzathine\nbezomil\nbuciclate\nbunapsilate\nbuteprate\nbutyl ester\ncarbesilate\np-chlorobenzenesulfonate\np-chlorobenzenesulphonate\nciclotate\ncipionate\nclosilate\nclosylate\ncrobefate\ncromacate\ncromesilate\ncyclopentanepropionate\ncyclotate\ncypionate\ndapropate\ndeanil\ndecil\ndibudinate\ndibunate\ndiethanolamine\ndigolil\nN,N-dimethyl-beta-alanine\ndiolamine\ndocosil\ndofosfate\nedamine\nedisylate\nepolamine\nerbumine\netabonate\nethanolamine\nethylenediamine\nfarnesil\nfendizoate\nfostedate\nhibenzate\nhybenzate\nhyclate\no-(4-hydroxybenzoyl)benzoate\nisocaproate\nlauril\nlaurilsulfate\nlaurilsulphate\nlauryl\nlaurylsulfate\nlaurylsulphate\nmegallate\nmetembonate\n4-methylbicyclo[2.2.2]oct-2-ene-l-carboxylate\nmofetil\noctil\nolamine\noxoglurate\npendetide\npivoxetil\nproxetil\nl-pyrrolidineethanol\nsodium lauril sulfate\nsodium lauril sulphate\nsodium lauryl sulfate\nsodium lauryl sulphate\nsteaglate\ntenoate\nteprosilate\ntetradecyl hydrogen phosphate\ntofesilate\ntriclofenate\ntriethanolamine\ntriflutate\ntrolamine\ntrometamol\ntromethamine\ntroxundate\nxinafoate\nANNEX IV\nINNs which shall no longer benefit from duty-free treatment\nCN code CAS RN Name\n2903\u00a022\u00a000 79-01-6 trichloroethylene\n2903\u00a030\u00a010 811-97-2 norflurane\n2903\u00a051\u00a010 58-89-9 lindane\n2906\u00a021\u00a000 100-51-6 benzyl alcohol\n2915\u00a029\u00a000 82279-57-0 zinc acetate, basic\n2922\u00a041\u00a000 56-87-1 lysine\n2922\u00a042\u00a090 56-86-0 glutamic acid\n2922\u00a049\u00a010 56-40-6 glycine\n2922\u00a050\u00a000 72-19-5 threonine\n2923\u00a010\u00a010 67-48-1 choline chloride\n2928\u00a000\u00a090 79-17-4 pimagedine\n2930\u00a090\u00a020 111-48-8 thiodiglycol\n2933\u00a090\u00a095 73-22-3 tryptophan\n3102\u00a070\u00a010 156-62-7 calcium carbimide\n3904\u00a061\u00a010 9002-84-0 politef\n3906\u00a090\u00a090 54182-57-9 carbomer\n3907\u00a020 0-00-0 macrogol ester\n3907\u00a020\u00a012 25322-68-3 macrogol\n3907\u00a020\u00a021 25301-02-4 tyloxapol\n3907\u00a060\u00a010 25038-59-9 pegoterate\n3908\u00a010\u00a000 25038-54-4 policapram\n3910\u00a000\u00a000 9006-65-9 dimeticone\n3912\u00a020\u00a011 9004-70-0 pyroxylin\n3912\u00a031\u00a000 9000-11-7 carmellose\n3912\u00a039\u00a080 8063-82-9 hypromellose"}